CN Patent

CN111057075B — Ret抑制剂及其制备方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2021-04-27 · 5y expired

What this patent protects

本发明涉及一种RET抑制剂及其制备方法。本发明所述的制备方法，其反应步骤较少，反应条件温和，使得反应产物的总产率大幅度提高、产物纯度达到99.5％以上，具备良好的经济优势。

USPTO Abstract

本发明涉及一种RET抑制剂及其制备方法。本发明所述的制备方法，其反应步骤较少，反应条件温和，使得反应产物的总产率大幅度提高、产物纯度达到99.5％以上，具备良好的经济优势。

Drugs covered by this patent

Patent Metadata

Patent number
CN111057075B
Jurisdiction
CN
Classification
—
Expires
2021-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.